JPRN-UMIN000012317招募中未知
Comparison of Tolvaptan and Carperitide in acute decompensated heart failure - Comparison of Tolvaptan and Carperitide in acute decompensated heart failure
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who already have tolvaptan at entry 2) Hypernatremia(serum Na>145mEq/L) 3) Insensitivity to thurst or difficulty in water intake 4) Anuria 5) Pregnant or possibly pregnant 6) History of hypersensitivity to Tolvaptan 7) Any conditions inappropriate to this trial deemed by the investigator
研究者
相似试验
已完成
不适用
Tolvaptan and Conventional Treatment for Acute Decompensated Heart FailureAcute decompensated heart failureJPRN-UMIN000018081agano Matsushiro General Hospital60
招募中
不适用
Effect of tolvaptan prodrug in patients with acute heart failure who continue oral tolvaptan therapyAcute heart failureJPRN-UMIN000047646Izumi City General Hospital50
招募中
4 期
Efficacy and safety of tolvaptan in Acute Heart FailureCTRI/2013/05/003643SRM Medical College Hospital Research Centre50
已完成
不适用
Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.Acute decompensated heart failureJPRN-UMIN000028039Iiyama redcross hospital60
尚未招募
不适用
The effects of tolvaptan treatment and copeptin concentration on renal prognosis in patients with chronic kidney disease or nephrotic syndrome, who have heart failure symptoms.Patients exhibit heart failure symptoms with chronic kidney disease (eGFR less than 60 mL/min/1.73 m2 for 3 months or more) or nephrotic syndrome (urinary protein excretion greater than 3.5 g/24hours, and hypoalbuminemia : less than 3.0 g/dL) .JPRN-UMIN000014980Department of Medicine, Kidney Center, Tokyo Women's Medical University50